Pursuing hot targets in drug discovery
publication date: Nov 28, 2006
Over the past few decades we have experienced a dramatic increase in the rate of emergence and re-emergence of infectious diseases. Many of these diseases, such as SARS, resulted in fewer than 1,000 deaths, but caused an estimated 2 per cent decline gross domestic product in East Asia. The economic impact of a pandemic influenza outbreak could result in the loss of millions of lives and cost an estimated 900 billion (US).
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.
Why should I register online with European Pharmaceutical Review?
